Dotmatics

Dotmatics helping scientists make better drugs in less time using AI

Dotmatics is leveraging artificial intelligence to accelerate pharmaceutical drug discovery by providing innovative AI-driven solutions that help scientists develop better drugs more efficiently, as highlighted in a CBS News Boston feature with company executives discussing their transformative impact on life sciences research.

CBS News: Dotmatics® helping scientists make better drugs in less time using AI

Latest Blogs

Case Studies

White Papers

Upcoming Events

News

Search

WBZ 12-5-23 Dotmatics 5am - Steve Tharp

Press O for more options

Video Thumbnail

Video Thumbnail

Click for sound

2:54

In this CBS News Boston feature, Dotmatics® executives Kalim Saliba and Steve Tharp discuss the groundbreaking impact of artificial intelligence (AI) in advancing scientific research and development for pharmaceutical drug discovery. Watch as they discuss how Dotmatics is utilizing AI to revolutionize the field, bringing innovative solutions to complex challenges in the life sciences sector.

Watch this feature on CBS News Boston to discover more about our cutting-edge work in AI and its pivotal role in shaping the future of scientific discovery.

Learn More About Dotmatics

Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.

Request a Demo of Dotmatics